On August 28, 2025 Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") reported that Dr. Helen Torley, President and Chief Executive Officer, and Tram Bui, VP of Investor Relations and Corporate Communications, are scheduled to participate and host investor meetings at the following investor conferences (Press release, Halozyme, AUG 28, 2025, View Source [SID1234655561]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details on the Company’s participation are as follows:

Event:

2025 Wells Fargo Healthcare Conference

Format:

Fireside Chat and 1×1 Meetings

Presentation Date:

Thursday, September 4, 2025

Presentation Time:

10:30am PT / 1:30pm ET

Location:

Boston, MA

Event:

Morgan Stanley 23rd Annual Global Healthcare Conference

Format:

Fireside Chat and 1×1 Meetings

Date:

Monday, September 8, 2025

Presentation Time:

4:45am PT / 7:45am ET

Location:

New York, NY

Event:

H.C. Wainwright 27th Annual Global Investment Conference

Format:

1×1 Meetings

Date:

Tuesday, September 9, 2025

Location:

New York, NY

A live audio webcast of the presentations will be available in the Investor Relations section of the Company’s website. Replays of the audio webcasts will be available for 90 days following the conference.